Skip to main content

Want a detailed portfolio tracker?

Genenta Science SpA (GNTA) P/E (2021 - 2026)

Genenta Science SpA (GNTA) P/E from Dec 15, 2021 to Jun 3, 2026. The TTM Genenta Science SpA (GNTA) P/E is -6.45. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Genenta Science SpA (GNTA)

YearP/EChange
2026-6.45+41.61%
2025-4.55-47.22%
2024-8.63-13.48%
2023-9.97-37.46%
2022-15.94-49.82%
2021-31.77N/A

Comparison Genenta Science SpA (GNTA) P/E with competitors

Genenta Science SpA (GNTA) P/E is -6.45.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.10-101.59%
ENLVEnlivex Therapeutics Ltd0.15-102.33%
FGENFibroGen Inc0.24-103.72%
TRAWTraws Pharma Inc0.47-107.33%
FBIOFortress Biotech Inc0.71-110.95%
CHRSCoherus Biosciences Inc0.98-115.17%
ORMPOramed Pharmaceuticals Inc1.47-122.86%
AGENAgenus Inc2.05-131.78%
VIVSVivoSim Labs Inc2.54-139.33%
INVAInnoviva Inc3.19-149.46%
CRMDCorMedix Inc3.65-156.55%
ABEOAbeona Therapeutics Inc4.20-165.23%
VXRTVaxart Inc4.26-166.10%
CVACCureVac N.V.4.45-168.96%
SRPTSarepta Therapeutics Inc4.62-171.73%
GLPGGalapagos NV4.86-175.37%
RIGLRigel Pharmaceuticals4.92-176.31%
ZVRAZevra Therapeutics Inc4.97-177.16%
ABUSArbutus Biopharma Corp5.69-188.32%
CGENCompugen Ltd7.38-214.54%
AUPHAurinia Pharmaceuticals Inc9.25-243.51%
ACADAcadia Pharmaceuticals Inc9.59-248.73%
OMEROmeros Corporation9.88-253.31%
PLXProtalix BioTherapeutics Inc9.91-253.71%
SPROSpero Therapeutics Inc10.73-266.52%
ADMAAdma Biologics Inc11.33-275.76%
SVASinovac Biotech Ltd11.44-277.39%
TBPHTheravance Biopharma Inc11.78-282.68%
HRMYHarmony Biosciences Holdings Inc12.18-288.94%
TGTXTG Therapeutics Inc13.18-304.44%
INCYIncyte Corp13.38-307.58%
SABSSAB Biotherapeutics Inc14.06-318.06%
XOMAXOMA Corp14.95-331.83%
REGNRegeneron Pharmaceuticals Inc14.98-332.37%
PBYIPuma Biotechnology Inc15.05-333.46%
EXELExelixis Inc15.79-345.01%
NAGENiagen Bioscience Inc16.35-353.70%
CPRXCatalyst Pharmaceuticals Inc17.34-369.05%
MDXGMimedx Group Inc17.38-369.53%
ARGXArgen X SE23.07-457.89%
HALOHalozyme Therapeutics Inc23.20-459.89%
XOMAOXOMA Corp25.34-493.15%
VRTXVertex Pharmaceuticals Inc25.66-497.97%
XOMAPXOMA Corp25.67-498.19%
CTMXCytomX Therapeutics Inc25.70-498.63%
ASNDAscendis Pharma A/S26.35-508.80%
RPRXRoyalty Pharma plc - Class A27.50-526.51%
SLNOSoleno Therapeutics Inc29.02-550.09%
LGNDLigand Pharmaceuticals Inc - Class B30.19-568.25%
BMRNBiomarin Pharmaceutical Inc37.51-681.81%
APLSApellis Pharmaceuticals Inc39.02-705.30%
KRYSKrystal Biotech Inc39.70-715.79%
ONCBeiGene Ltd67.03-1139.72%
TECHBio-Techne Corp68.59-1164.05%
VCELVericel Corp80.63-1350.72%
PHARPharming Group N.V.87.74-1461.03%
ALNYAlnylam Pharmaceuticals Inc124.93-2037.97%
TLXTelix Pharmaceuticals Ltd139.89-2269.99%
CORTCorcept Therapeutics Inc158.39-2556.94%